Blood clotting in cancer patients with clotting problems
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how blood clotting problems affect people with cancer. It tests whether certain cancers or severe infections cause changes in the body's ability to break down blood clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are currently in the hospital for emergency, intensive care, hematology, oncology, or liver surgery
- You have a blood clotting problem: low platelets (under 100) and high INR (over 1.2)
- You have either a blood cancer (like leukemia or lymphoma with large tumor masses), a solid tumor (prostate, pancreatic, bile duct, or metastatic digestive tract cancer), or septic shock (a severe infection)
- You are not pregnant, weigh at least 50 kg, are not on blood thinners, and have no active bleeding, cirrhosis, or bleeding disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes patients with blood clotting or bleeding disorders over time to collect health information and improve care.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
Hear when a new Disseminated Intravascular Coagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.